New Hodgkin Lymphoma Drug Shows Promise

There were only 23 participants in the trial, but the results are encouraging. For 87% of patients the drug was effective at reducing tumors,and for 17% of the patients it was really effective… meaning the tumor was either completely gone or very nearly so.

This article was sourced from:

Andrew Pollack, New York Times


Josh Wolsky

Developer & Writer @TheMinot Voice, Fan of the Souris River, There's a lot to Savor about Minot. Fortunate to be a 'former' City Council member ;)

Leave a Reply

Your email address will not be published.